<DOC>
	<DOCNO>NCT02624440</DOCNO>
	<brief_summary>This study evaluate effect prophylactic antibiotic multiple myeloma . One third patient receive treatment clarithromycin , one third patient receive treatment sulfamethoxazole/trimethoprim one third observe without prophylactic antibiotic . All patient receive concurrent anti-myeloma treatment .</brief_summary>
	<brief_title>Clarithromycin , Sulfamethoxazole/Trimethoprim Observation Newly Diagnosed Multiple Myeloma</brief_title>
	<detailed_description>There need improvement prognosis elderly myeloma patient . The patient fragile due age severe comorbidity . Infections frequent course initial myeloma treatment contribute high morbidity mortality elderly patient . Furthermore infection often lead delay myeloma treatment dose reduction . The use primary antibiotic prophylaxis might influence frequency complication . In study myeloma patient ineligible high-dose melphalan stem cell support randomise either p.o . clarithromycin 250 mg twice daily 180 day , p.o . sulfamethoxazole/trimethoprim 400/80 mg twice daily 180 day observation without prophylactic antibiotic . All patient receive concurrent myeloma treatment discretion treat physician . The choice anti-myeloma treatment settle randomization . The study evaluate frequency infection patient treat clarithromycin , sulfamethoxazole/trimethoprim observation</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Sulfamethoxazole</mesh_term>
	<mesh_term>Trimethoprim</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Trimethoprim , Sulfamethoxazole Drug Combination</mesh_term>
	<criteria>Myeloma diagnosis accord IMWG criterion Treatment demand disease Signed informed consent give prior study related activity , except bone marrow sample diagnosis , FISH , biobanking , skeletal xray Age &gt; 18 year Allogeneic transplantation schedule part treatment Highdose melphalan stem cell support schedule part treatment Myeloma treatment prior entry study , except radiotherapy , bisphosphonates/denusumab corticosteroid symptom control Concurrent disease make clarithromycin sulfamethoxazole/trimethoprim treatment unsuitable Positive pregnancy test ( applicable woman childbearing potential ) Known suspect hypersensitivity intolerance claritromycin , sulfamethoxazole trimethoprim Prolonged QT correct ( QTc ) interval ( &gt; 500 msec screen ECG ) Concurrent treatment cabergoline , fluconazole , ketoconazole , pimozide , quetiapine , sirolimus , verapamil , tacrolimus , ergot alkaloid methotrexate Uncontrolled severe cardiovascular disease include myocardial infarction within 6 month enrolment , uncontrolled angina know cardiac amyloidosis Severe renal dysfunction ( estimate creatinine clearance &lt; 10 mL/min ) Serious medical psychiatric illness , judgment investigator , would make patient inappropriate entry study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Multiple Myeloma</keyword>
	<keyword>Infection</keyword>
	<keyword>Clarithromycin</keyword>
	<keyword>Trimethoprim-Sulfamethoxazole Combination</keyword>
</DOC>